Clinical evolution

EXCLUSIVE STUDY

Open source paradigm could swipe biz from CROs: Beroe

27-Sep-2012 - Open source drug developers could swipe business from CROs in the drug discovery field, according to Beroe.

Clinical trials should involve the elderly more, say experts

19-Sep-2012 - Geriatric patients are left out of trials too often say experts who want researchers to 'open their minds' to the benefits of recruiting the elderly.

Improving Biopharma R&D efficiency a mixed blessing for CROs

06-Sep-2012 - Improving efficiency in biopharma research is a “mixed blessing” for contract research organisations (CROs), according to Wells Fargo.

Online drug accountability systems will replace paper, says Cenduit

04-Sep-2012 - Automated drug accountability systems are becoming “the norm” in clinical trials because they can improve compliance and cut working time drastically, according to Cenduit.

Is cloud computing hot air? Comprehend Systems shoots the breeze with OSP

23-Aug-2012 - Comprehend Systems recently made its data analytics, visualisations and reports software available from the cloud. CEO Rick Morrison spoke with Outsourcing-Pharma.com about the firm’s reasoning, and why no rockets were...

Changes to EU clinical trial laws will mean fairer playing field, says Clinipace

21-Aug-2012 - The proposed changes to European clinical trial regulations accepted by the European Commission (EC) in July  will put Europe on an equal playing field, according to Clinipace’s Andrea Schiefer....

DaVita opens PI facility for kidney research

20-Aug-2012 - DaVita Clinical Research has opened a Phase I facility focussed on kidney research in a bid to meet a “growing demand” for renal trials.

Theorem and Gallus team up to help drugsmakers in emerging markets go State side

16-Aug-2012 - Theorem and Gallus say their new biologics manufacturing partnership is aimed at giving a “leg up” to drugsmakers in emerging markets looking to market products in the US.

Icon readies itself for translational medicine boom with Manchester expansion

14-Aug-2012 - Icon has boosted its Phase I translational medicine services in Manchester, UK, in preparation for what it believes will be a boom in the drug development area.

Exclusive interview

Cherry picking best functionalities is key, Bioclinca CEO tells OSP

13-Aug-2012 - BioClinica says the next eClinical revolution will be in programmes combining functionalities tailored to a client's specific needs.

EXCLUSIVE

Big Pharma looking to home care to bolster clinical activities: ResearchNurses.co

09-Aug-2012 - ResearchNurses.co will conduct home visits in clinical trials for three Big Pharma firms after forging an agreement with Nottingham University Hospitals Research and Innovation Department.

New pharma services from M&A and partnerships: round-up

07-Aug-2012 - Outsourcing-Pharma.com presents the low down on new services forged by partnerships and M&A (mergers and acquisitions), including a molecular biology offering for Quotient, Onyx’s added purification and separation capabilities, and...

Medidata beats Q2 expectations following landmark $100m contract

01-Aug-2012 - Medidata beat analyst expectations in this year’s Q2 results after inking a five-year $100m clinical cloud deal – the largest in the firm’s history.

BioFocus and Activiomics team up to boost drug candidate selection

31-Jul-2012 - BioFocus and Activiomics have teamed up to offer a drug discovery and biomarker service which it says will improve the identification of novel targets.

Payment based on CRO results is the wave of the future: iGate

30-Jul-2012 - Outcome-based payment for CRO services is the “wave of the future” for pharmaceutical outsourcing, according to iGate.

iGATE says new data management tech will change R&D

09-Jul-2012 - iGATE says its new information management platform will provide a 70 per cent decrease in content management costs for the drug development process.

EXCLUSIVE

CDMO and CRO must become one so clinical research can evolve: Quotient.

05-Jul-2012 - ‘Merge CDMO and CRO activities to fix the holes in the early phase clinical research industry’, said Quotient Clinical’s CEO Mark Egerton.

Argentina's CRO market set to boom, says report

04-Jul-2012 - Argentina’s clinical trial market will hit $76m (EUR60.4) by 2015 with growth driven by low costs, a good regulatory environment and large patient populations, according to a new study.

Over 25% of clinical trial procedures are pointless, says Medidata

02-Jul-2012 - A quarter of procedures carried out during clinical trials may be pointless according to a new study, which suggests that this unnecessary work costs around $5bn (€3.96bn) a year. ...

Do good performances always mean big bucks for CROs? ISR asks

28-Jun-2012 - It seems service quality really does mean bigger profits for CROs serving the pharma and biopharma industries, according to Industry Standard Research’s (ISR) new report.

DIA 2012: eClinical firms put integration on centre stage

28-Jun-2012 - eClinical integration was a hot topic at DIA this week with OmniComm, Datatrak and Merge Healthcare all showing updated systems.

UPDATE

UPDATES from DIA 2012: "Collaborate to innovate," says the association

27-Jun-2012 - “Collaborate to innovate,” is the message DIA has for clinical researchers at its 2012 Annual Meeting in Philadelphia, US.

Quotient & Capsugel partner on lipid formulation services

26-Jun-2012 - Quotient and Capsugel have teamed up to tackle drug delivery challenges in lipid-based formulations with new assessment and development services.

Roowin takes over old Schering-Plough plant, boosts small scale GMP services

26-Jun-2012 - Roowin says it will be one of the first small batch GMP makers for Phase I & II clinical trials after moving into a new facility in Riom, France.

UPDATE

Quintiles boosts lab testing in China

21-Jun-2012 - Quintiles has teamed up with the Shanghai Clinical Research Centre (SCRC) to ramp-up its biopharmaceutical lab testing services in China.